Biotechs harness AI in battle against Covid-19

FINANCIAL TIMES

Zegami, a data visualisation spinout from Oxford University, has developed a machine learning tool that aims to diagnose Covid-19 from lung X-rays. The company says it could not only differentiate Covid-19 from pneumonia caused by other pathogens, but could also predict likely outcomes based on the experience of previous patients.

To improve its AI tool, Zegami asked the UK’s National Health Service to provide it with data in the form of Covid-19 X-rays and details of patients’ treatment and outcome.

“Covid-19 is a huge challenge and technology should play a key role in defeating it,” says Roger Noble, the company’s chief executive.

This article has been written by Clive Cookson and first published on 15th of May 2020.

Read the full FT article.